Multicenter trial of everolimus in pediatric renal transplant recipients: Results at three year

Pediatric Transplantation

Volumn 12, Issue 4, 2008, Pages 456-463

  Ettenger, Robert ^a   Hoyer, Peter Friedrich ^b   Grimm, Paul ^c   Webb, Nicholas ^d   Loirat, Chantal ^e   Mahan, John D ^f   Mentser, Mark ^g   Niaudet, Patrick ^h   Offner, Gisela ⁱ   Vandamme Lombaerts, R ^j   Hexham, J Mark ^k   Herman, J ^l   Vester, U ^l   Roberts, D ^l   Rordorf, C ^l   Kovarik, J M ^l   McMahon, L ^l  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^e HÔPITAL ROBERT DEBRÉ   (France)

^f NATIONWIDE CHILDREN S HOSPITAL   (United States)

^g CHILDREN S HOSPITAL LOS ANGELES   (United States)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

ⁱ HANNOVER MEDICAL SCHOOL   (Germany)

^j UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^k NOVARTIS PHARMA AG   (Switzerland)

^l NONE

more..

Author keywords

Cyclosporine; Everolimus; mTOR; Pediatric; Renal transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BASILIXIMAB; CALCINEURIN INHIBITOR; CHOLESTEROL; CREATININE; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; EVEROLIMUS; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 2 RECEPTOR ANTIBODY; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STATINE DERIVATIVE; TRIACYLGLYCEROL;

ACUTE GRAFT REJECTION; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHRONIC GRAFT REJECTION; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FEVER; GASTROENTERITIS; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; MALE; MULTICENTER STUDY; NEOPLASM; NEUTROPENIA; PATIENT COMPLIANCE; PNEUMONIA; PYELONEPHRITIS; RHINITIS; RHINOPHARYNGITIS; SCHOOL CHILD; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VIRUS INFECTION;

ADOLESCENT; ADRENAL CORTEX HORMONES; BIOPSY; CHILD; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; SIROLIMUS; TREATMENT OUTCOME;

EID: 43249103406     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00832.x     Document Type: Article

References (23)